温卡明,从抗氧化剂和大脑血管扩展剂到其抗癌潜力
Yulin Ren1, Kevin DeRose1, Leyan Li1
1Division of Medicinal Chemistry and Pharmacognosy, College of Pharmacy, The Ohio State University, Columbus, OH 43210, United States.
Bioorganic & medicinal chemistry
|August 14, 2023
概括
温卡胺是一种具有抗氧化特性的醇,通过表现出细胞毒性和调节参与瘤生长的关键蛋白质,显示出潜在的抗瘤活性. 本综述探讨了其发展和抗癌机制,以发现新的瘤治疗剂.
科学领域:
- 药理学 药理学是指药理学的学科.
- 自然产品 化学 化学
- 在瘤学瘤学.
背景情况:
- 温卡明是一种天然存在的类类物质,具有经过记录的抗氧化活性.
- 抗氧化剂因其在癌症治疗中的潜在作用而得到认可.
- 芬卡明在脑血管疾病中的确定的使用为探索其更广泛的治疗应用提供了基础.
研究的目的:
- 审查卡胺作为治疗剂的发现和发展.
- 为了总结温卡明的抗氧化和抗瘤活动.
- 描述卡胺抗癌潜力的抗氧化剂相关机制,并讨论基于卡胺的色剂的设计.
主要方法:
- 对芬卡明的药理性质和临床前研究的文献综述.
- 对温卡明对癌细胞细胞毒性影响的分析.
- 研究温卡明对瘤生长途径中的关键蛋白质的调节 (AChE,MAPK,NF-κB,Nrf2,TBX3).
主要成果:
- 文卡明对癌细胞表现出细胞毒性.
- 文卡明调节瘤进展中涉及的关键蛋白质,包括乙胆化酶 (AChE),甲基因激活蛋白激酶 (MAPK),核因子-κB (NF-κB),核因子红色素2相关因子2 (Nrf2) 和T-box3 (TBX3).
- 芬卡明的抗氧化特性与其抗癌潜力有关.
结论:
- 芬卡明表现出有前途的抗瘤活性,其抗氧化作用和关键癌症相关蛋白质的调节支持.
- 进一步开发基于胺的药物有可能为新型癌症疗法提供潜力.
- 芬卡明代表了一种有价值的化合物,用于发现新的瘤解毒剂.
相关概念视频
01:29Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists
332
Dopamine receptor antagonists, also known as antipsychotic agents, are critical in managing chemotherapy-induced vomiting. These antiemetic agents block dopamine receptors in the chemoreceptor trigger zone (CTZ), inhibiting signal transmission to the vomiting center. Antipsychotic agents encompass phenothiazines (PTZ), butyrophenones, benzamides, and thienobenzodiazepines (Zyprexa), which are utilized for their antiemetic and sedative properties.
Phenothiazines, such as prochlorperazine...
Phenothiazines, such as prochlorperazine...
332
01:10Drugs that Destabilize Microtubules
2.0K
Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
2.0K
01:28Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
199
Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy. SP binds and activates...
199
01:25Antianginal Drugs: Calcium Channel Blockers and Ranolazine
561
Angina pectoris, a primary symptom of ischemic heart disease, requires careful pharmacological interventions. In this context, calcium channel blockers (CCBs) and ranolazine have emerged as crucial pharmacotherapeutic agents, providing deep insights into the complexities of angina management.
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
561
01:46Electron Transport Chain: Complex I and II
14.5K
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
ROS generation is regulated and maintained at moderate levels necessary...
14.5K
01:21Chemotherapy-Induced Nausea and Vomiting: Cannabinoids
315
Tetrahydrocannabinol (THC) is a phytocannabinoid that primarily interacts with the CB1 receptor, a type of G protein-coupled receptor (GPCR) predominantly in and around the chemoreceptor trigger zone (CTZ) and emetic center. THC also blocks the serotonin receptor activity in the dorsal vagal complex (DVC) by inhibiting serotonin release. THC exerts its anti-emetic effects through these interactions, which are beneficial for patients undergoing chemotherapy.
Two synthetic agonists of THC,...
Two synthetic agonists of THC,...
315